4 / 7 / 2025
By Christine Scifert, Dawn Norman, David White & Drew Hoffman
Introduction and Value Managing risk and uncertainty in the world of investment is a critical advantage. Investing in the medical device industry offers tremendous potential for returns, driven by constant...
5 / 23 / 2024
By Ann Brandt
Pharmaceutical, medical device, and biotechnology companies (collectively life sciences companies or “LSCs”) utilize outside ‘experts’ (“Healthcare Professionals” and “Key Opinion Leaders”, collectively “HCPs/KOLs”) to provide a wide variety of...
10 / 10 / 2023
By Ann Brandt
In many countries and regions of the world, access to valid, reliable, and comprehensive healthcare professional (“HCP”) compensation data can be a challenging task. Notwithstanding, in countries outside of...
